Skip to Content

Ferriprox Approval History

FDA Approved: Yes (First approved October 14, 2011)
Brand name: Ferriprox
Generic name: deferiprone
Dosage form: Tablets
Company: ApoPharma Inc.
Treatment for: Hemosiderosis

Ferriprox (deferiprone) is an iron chelator indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.

Development History and FDA Approval Process for Ferriprox

Oct 14, 2011Approval FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
Sep 14, 2011ApoPharma Announces FDA Advisory Committee Recommendation in Favor of Ferriprox (deferiprone) Approval

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.